Senior Project Manager, Research & Development at Abata Therapeutics

Brisbane, California, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Advanced degree (MS, PhD, or equivalent) in life sciences or a related field strongly preferred
  • Minimum of 6+ years of industry experience, including hands-on biologics research with demonstrated project or timeline management responsibilities
  • Proven track record of managing programs from research through IND filing
  • Deep understanding of biologics

Responsibilities

  • Support day-to-day planning and coordination of biologics research programs, ensuring execution of key activities from discovery through IND-enabling work
  • Build and maintain project timelines that capture critical milestones, dependencies, and deliverables
  • Partner with scientific leads and functional stakeholders to align on scope, priorities, and progress
  • Collaborate with scientific teams to define key project milestones, decisional experiments and translate into actionable, resource-informed timelines
  • Help compile project data, timelines, risks, and trade-offs to support informed decision-making
  • Coordinate and facilitate planning and documentation of decisive experiments, and update project plans based on results and next steps
  • Facilitate cross-functional collaboration across research to ensure effective communication and documentation of decisions, alignment of priorities and timelines
  • Schedule and run cross-functional meetings, ensuring clear agendas, effective documentation, and follow-up on action items
  • Monitor interdependencies across functions and proactively identify, flag and resolve conflicts across workstreams
  • Track project status, risks, and mitigation strategies; provide updates to internal stakeholders
  • Coordinate with functional leads to understand resource needs and potential impacts to timelines
  • Contribute to scenario planning and contingency thinking for critical path activities
  • Identify operational challenges and recommend improvements to enhance efficiency and coordination
  • Work closely with functional and team leads to understand resourcing needs, identify gaps and timeline impacts
  • Develop scenario plans for critical path development decisions to support contingency and investment planning to address potential delays, bottlenecks, or shifts in scope

Skills

Project Management
Biologics R&D
Timeline Management
Milestone Tracking
Cross-Functional Collaboration
IND-Enabling Studies
Scientific Planning
Stakeholder Coordination

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI